Kestra expects $137M FY2027 revenue while targeting 70%+ gross margins in the next few years (NASDAQ:KMTS)

Kestra Medical (KMTS) Q4 FY2026 earnings call recap: 66% revenue growth, margin expansion, $137M FY2027 outlook, WCD share gains & financing—read now.

Read on WOBR AI →